Atrial Fibrillation Pipeline Product and Technology Analysis Report

Atrial Fibrillation Pipeline Product and Technology Analysis Report

Summary

GlobalData's “Pipeline Products and Technology Analysis Report” is an essential source of information and analysis on pipeline medical devices, which are expected to bring significant shift to the prevalent market landscape. We keep our subscribers abreast of the very latest technological developments by providing them with our independent and unbiased judgment on the implications of each development within the industry. While the objective is to review specific pipeline devices and technologies, the report also provides a holistic overview of the existing products, the market structure and the competitive landscape.

Scope

• Analysis and review of the key pipeline devices that are likely to impact the treatment landscape globally;
• Independent analysis of the product details, indication details and clinical trial status with projections on the market potential;
• Review of existing competing technologies and the competitive landscape;
• Review and analysis of the trends, drivers and restraints shaping and defining the markets that the products are being targeted in;
• In-depth analysis of the device-specific developments, strategic partnerships and other details expected to influence the launch and market penetration.

Reasons to buy

• Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline;
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies;
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage; and
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Summary

3 Atrial Fibrillation Market Overview

3.1 Global Atrial Fibrillation Market Analysis

3.2 Atrial Fibrillation Trend Assessment

3.2.1 Market Drivers

3.2.2 Market Restraints

3.3 Competitive Landscape

3.4 Clinical Trial Comparisons

3.4.1 STOP AF Clinical Trial:

3.4.2 Tailored Treatment of Permanent Atrial Fibrillation (TTOP AF), Clinical Trial

3.4.3 Multi-Array Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation” or MAP-PAF Trial

3.5 Technology Description

3.5.1 Cyberknife Robotic Radio Surgery Technology

3.5.2 Instinctive Fine Force Technology

3.5.3 Ensite NavX Navigation and Visualization Technology

3.6 Energy Source Comparisons:

3.7 Atrial Fibrillation Pipeline Products

3.7.1 Pipeline Products using Cryo Energy

3.7.2 Pipeline Products using RF Energy

4 Outlook and Implications

5 Global Atrial Fibrillation Pipeline Product Summary

6 Global Atrial Fibrillation Pipeline Trial Summary

7 Appendix

7.1 Research Methodology

7.2 Coverage

7.3 Secondary Research

7.4 Primary Research

7.5 Models

7.6 Forecasts

7.7 Expert Panels

7.8 GlobalData Consulting

7.9 Contact Us

7.10 Disclaimer

1.1 List Of Tables

Table 1: Comparison Between Cryo and Radiofrequency (RF) Energy Sources

Table 2: AFib Pipeline Products Global,2008

Table 3: Arctic Front Catheter Product Status

Table 4: Arctic Front Catheter Product Description

Table 5: Arctic Front Catheter Clinical Trials 1

Table 6: Arctic Front Catheter Clinical Trials 2

Table 7: Catheter to treat Atrial Fibrillation Product Status

Table 8: Catheter to treat Atrial Fibrillation Product Description

Table 9: Cryo Balloon Catheter Product Status

Table 10: Cryo Balloon Catheter Product Description

Table 11: Cryo Balloon Catheter Patent Details

Table 12: CryoCor Cryoablation System Product Status

Table 13: CryoCor Cryoablation System Product Description

Table 14: CryoCor Cryoablation System Clinical Trials 1

Table 15: CryoCor Cryoablation System Clinical Trials 2

Table 16: CryoCor Cryoablation System Clinical Trials 3

Table 17: CryoCor Cryoablation System Clinical Trials 4

Table 18: CryoCor Cryoablation System Clinical Trials 5

Table 19: CryoCor Cryoablation System Clinical Trials 6

Table 20: CryoCor Cryoablation System Patent Details

Table 21: Bard Pulsed RF Ablation System Product Status

Table 22: Bard Pulsed RF Ablation System Product Description

Table 23: Bard Pulsed RF Ablation System Clinical Trials

Table 24: Bard Pulsed RF Ablation System Patent Details

Table 25: CathRx 4 mm Therapeutic Catheter Product Status

Table 26: CathRx 4 mm Therapeutic Catheter Product Description

Table 27: CathRx 4 mm Therapeutic Catheter Patent Details

Table 28: Pulmonary Vein Ablation Catheter Product Status

Table 29: Pulmonary Vein Ablation Catheter Product Description

Table 30: Pulmonary Vein Ablation Catheter Clinical Trials

Table 31: Pulmonary Vein Ablation Catheter Patent Details

Table 32: Micro-Loop Catheter Product Status

Table 33: Product Description

Table 34: Atrial Fibrillation, Pipeline Product Details

Table 35: Atrial Fibrillation, Clinical Trial Details

1.2 List of Figures

Figure 1: Comparison of Normal Heart Rate and Atrial Fibrillation

Figure 2: Global Electrophysiology Market Revenues by Category, ($ m), 2007-2012

Figure 3: Global Electrophysiology Market Share, (%), 2007

Figure 4: GlobalData Methodology